Wuhan Biofriend Technology Co.,Ltd

Top Grade Biotechnology Manufacturer In China

Quality Product Safe Delivery Professional Service

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAnti Estrogen Steroids

Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic

Good quality Injectable Anabolic Steroids for sales
Good quality Injectable Anabolic Steroids for sales
Everything is perfect!The quality,prices and shipping!I will buy from you every month.

—— Carlos

The package is complete when i have it!Everything are perfect!Thank you Corleone and i will be keeping ordering!!

—— Blaker

I'm Online Chat Now

Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic

China Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic supplier
Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic supplier Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic supplier

Large Image :  Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic

Product Details:

Place of Origin: Wuhan
Brand Name: Biofriend
Certification: SGS,ISO9001,UKAS,GMP
Model Number: 84449-90-1

Payment & Shipping Terms:

Minimum Order Quantity: 10g
Price: Negotiable
Packaging Details: Discreet ways of packing for customs guaranteed
Delivery Time: Within 24 hours after payment
Payment Terms: T/T, Western Union, MoneyGram,Bitcoin,Paypal
Supply Ability: 2000kg Per Month
Contact Now
Detailed Product Description
MF: C28H27NO4S MW: 473.58
Purity: 99.5% Appearance: White Powder
Grade: Pharmaceutical Grade Packing:: Aluminum Foil Bag

Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic

 

CAS 84449-90-1 Raloxifene
 
Product Name:Raloxifene
Alias:Evista
CAS NO.:84449-90-1
Molecular Formula:C28H27NO4S
Molecular Weight:473.58
Purity:99%
Appearance:Light Yellow Powder
Grade:Pharmaceutical Grade
 
Safe Delivery Best Price High Quality Raloxifene Hydrochloride Steroid Anabolic
Selective estrogen receptor modulators
 
Selective estrogen receptor modulators (SERMs) are non-estrogenic, non-estrogenic, and nonsteroidal compounds. Because of the different types and numbers of estrogen receptors in different tissues, SERMs are selective for different tissues and exhibit estrogen agonistic or estrogen antagonistic effects. The study found that SERMs in bone and lipoprotein in the performance of estrogen agonistic role, can inhibit bone resorption of osteoclasts, osteoblasts to promote osteogenesis, while regulating blood lipids and cholesterol, reduce low density lipoprotein cholesterol, Increase in high-density lipoprotein cholesterol, but does not increase triglyceride; and in the breast and endometrium but showed estrogen antagonistic effect, can inhibit the proliferation of breast and endometrial. Therefore, the emergence of this drug to avoid or reduce the carcinogenicity of hormone replacement therapy provides a research direction. In recent years, the clinical use of SERMs have been replaced by estrogen for postmenopausal women with osteoporosis.
 
 
Oral SERM
 
Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
 
Specifically, Raloxifene is a non-steroidal SERM belonging to the benzothiophene family. Raloxifene is very similar in its mode of action as Nolvadex (Tamoxifen), and does exhibit both Estrogen agonist as well as Estrogen antagonist effects in different tissues throughout the body. In particular, Raloxifene serves as an Estrogen antagonist in breast tissue and uterine tissue while at the same time acting as an Estrogen agonist in bone tissue. Raloxifene is in fact utilized in medicine in the prevention of osteoporosis in post-menopausal females due to its estrogenic activity in bone. In contrast, Nolvadex is known to act as an Estrogen antagonist in bone, which obviously presents a problem for female breast cancer patients who have been prescribed the use of Nolvadex. Considering these properties, it is therefore understandable why Raloxifene had demonstrated some clear advantages over Nolvadex, and has proven itself as a novel new drug in the treatment of various post-menopausal diseases in female patients.
 
 
Raloxifene Advantage
 
Because of Raloxifene’s greater differences in its selectivity of Estrogen agonism and antagonism in different tissues in the body, there is ongoing investigation of its application in other diseases, including prostate cancer, acromegaly, uterine cancer, cardiovascular disease, and breast cancer.
 
Bodybuilders and anabolic steroid users are attracted to the use of Raloxifene due to its nature as an anti-estrogen in the fight against Estrogen-related side effects that are usually caused by the use of aromatizable androgens that result in high blood plasma levels of Estrogen in the body. A common estrogenic side effect as a result of this is the development of gynecomastia. In the realm of gynecomastia in particular, Raloxifene has actually demonstrated more promising effectiveness than Nolvadex (Tamoxifen).
 
As is common with all SERMs and anti-estrogens, Raloxifene has also demonstrated considerable benefit in stimulating endogenous natural Testosterone production in males, as studies have demonstrated an increase of serum Testosterone levels by 20% from 120mg of Raloxifene per day.
 
 
Raloxifene Dosage
 
The recommended dosage is one 60 mg EVISTA (raloxifene) tablet daily, which may be administered any time of day without regard to meals.

Contact Details
Wuhan Biofriend Technology Co.,Ltd

Contact Person: Ian

Send your inquiry directly to us (0 / 3000)